BRITTANY HALL: Open Payments
NPI 1841704996 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 69 payments from 13 companies in 2025. Trend: 2023 $1,312 · 2024 $1,305 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $209 |
| Amgen Inc. | 13 | $207 |
| Novartis Pharmaceuticals Corporation | 11 | $182 |
| Novo Nordisk Inc | 9 | $136 |
| PFIZER INC. | 6 | $108 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $102 |
| AstraZeneca Pharmaceuticals LP | 2 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| ENDOTRONIX, INC. | 1 | $34 |
| SCPHARMACEUTICALS INC. | 1 | $33 |
Products named: VERQUVO, REPATHA, LEQVIO, Wegovy, LifeVest, ELIQUIS, AIRSUPRA, VYNDAQEL.
Industry payments across IN — which companies pay providers there.
